Synthesis and Biological Examination of Novel Tetra Pyranopyrimidine Heterocycles Contained Lipophilic Spacers

References

• A. Dömling, “Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry,” Chemical Reviews 106, no. 1 (2006): 17–89. doi:10.1021/cr0505728.
   PubMed Web of Science ®Google Scholar
• A. Maleki, V. Eskandarpour, J. Rahimi, and N. Hamidi, “Cellulose Matrix Embedded Copper Decorated Magnetic Bionanocomposite as a Green Catalyst in the Synthesis of Dihydropyridines and Polyhydroquinolines,” Carbohydrate Polymers 208 (2019): 251–60. doi:10.1016/j.carbpol.2018.12.069.
   PubMed Web of Science ®Google Scholar
• A. R. Bhat, A. H. Shalla, and R. S. Dongre, “Synthesis of New Annulated Pyrano [2, 3-d] Pyrimidine Derivatives Using Organo Catalyst (DABCO) in Aqueous Media,” Journal of Saudi Chemical Society 21 (2017): S305–S310. doi:10.1016/j.jscs.2014.03.008.
   Web of Science ®Google Scholar
• S. Makarem, A. Mohammadi, and A. Fakhari, “A Multi-Component Electro-Organic Synthesis of 2-Amino-4H-Chromenes,” Tetrahedron Letters 49, no. 50 (2008): 7194–6. doi:10.1016/j.tetlet.2008.10.006.
   Web of Science ®Google Scholar
• H. M. Aly and M. M. Kamal, “Efficient One-Pot Preparation of Novel Fused Chromeno[2,3-d]Pyrimidine and Pyrano[2,3-d]Pyrimidine Derivatives,” European Journal of Medicinal Chemistry 47, no. 1 (2012): 18–23. doi:10.1016/j.ejmech.2011.09.040.
   PubMedGoogle Scholar
• G. Brahmachari and B. Banerjee, “Facile and One-Pot Access to Diverse and Densely Functionalized-2-Amino-3-Cyano-4 H-Pyrans and Pyran-Annulated Heterocyclic Scaffolds via an Eco-Friendly Multicomponent Reaction at Room Temperature Using Urea as a Novel Organo-Catalyst,” ACS Sustainable Chemistry & Engineering 2, no. 3 (2014): 411–22. doi:10.1021/sc400312n.
   Web of Science ®Google Scholar
• S. Maddila, K. Nagaraju, and S. B. Jonnalagadda, “Synthesis and Antimicrobial Evaluation of Novel Pyrano [2, 3-d]-Pyrimidine Bearing 1, 2, 3-Triazoles,” Chemical Data Collections 28 (2020): 100486. doi:10.1016/j.cdc.2020.100486.
   Google Scholar
• F. Eiden and F. Denk, “Synthesis of CNS-Activity of Pyran Derivatives: 6,8-Dioxabicyclo(3,2,1)Octane,” Archiv Der Pharmazie 324, no. 6 (1991): 353–4. doi:10.1002/ardp.19913240606.
   PubMed Web of Science ®Google Scholar
• A. H. F. Abd El-Wahab, H. M. Mohamed, A. M. El-Agrody, and A. H. Bedair, “The Chemical Reactivity of Naphthols and Their Derivatives toward α-Cyanocinnamonitriles and Ethyl α-Cyanocinnamates: A Review of Synthesis, Reactions and Applications of Naphthopyrano,” European Journal of Chemistry 4, no. 4 (2013): 467–83. doi:10.5155/eurjchem.4.4.467-483.775.
   Google Scholar
• C. Shishoo, M. Devani, G. Ullas, S. Ananthan, and V. Bhadti, “Studies in the Synthesis and Interconversion of Isomeric Triazolothienopyrimidines,” Journal of Heterocyclic Chemistry 18, no. 1 (1981): 43–6. doi:10.1002/jhet.5570180109.
   Web of Science ®Google Scholar
• C. Shishoo, M. Devani, G. Ullas, S. Ananthan, and V. Bhadti, “Studies on the Synthesis of 2‐(2‐Arylvinyl) Thieno [2, 3‐d] Pyrimidines and 5‐(2‐Arylvinyl) Triazolothieno [3, 2‐e] Pyrimidines,” Journal of Heterocyclic Chemistry 22, no. 3 (1985): 825–30.
   Web of Science ®Google Scholar
• M. A. M. A. Reheim, I. S. A. Hafiz, and S. Mohamed, “Utility of β-Diketones in Heterocyclic Synthesis: Synthesis of New Tetrahydro-Pyrimidinethione, Pyrazole, Thiophene, Dihydropyridine, Dihydropyrane, Pyridazine Derivatives and Investigation of Their Antimicrobial Activity,” European Journal of Chemistry 7, no. 3 (2016): 298–308. doi:10.5155/eurjchem.7.3.298-308.1447.
   Google Scholar
• M. Mohsenimehr, M. Mamaghani, F. Shirini, M. Sheykhan, and F. A. Moghaddam, “One-Pot Synthesis of Novel Pyrido [2, 3-d] Pyrimidines Using HAp-Encapsulated-γ-Fe2O3 Supported Sulfonic Acid Nanocatalyst under Solvent-Free Conditions,” Chinese Chemical Letters 25, no. 10 (2014): 1387–91. doi:10.1016/j.cclet.2014.04.025.
   Web of Science ®Google Scholar
• L. Yang, D. Shi, S. Chen, H. Chai, D. Huang, Q. Zhang, and J. Li, “Microwave-Assisted Synthesis of 2, 3-Dihydropyrido [2, 3-d] Pyrimidin-4 (1 H)-Ones Catalyzed by DBU in Aqueous Medium,” Green Chemistry 14, no. 4 (2012): 945–51. doi:10.1039/c2gc16469h.
   Web of Science ®Google Scholar
• Z. Ismail, M. Ghorab, E. Mohamed, H. Aly, and M. El-Gaby, “Antitumor Activity of Some Novel 1, 2, 5-Thiadiazole Derivatives,” Phosphorus, Sulfur, and Silicon 183, no. 10 (2008): 2541–54. doi:10.1080/10426500801967815.
   Web of Science ®Google Scholar
• M. El-Gaby, S. Abdel-Gawad, M. Ghorab, H. Heiba, and H. Aly, “Synthesis and Biological Activity of Some Novel Thieno [2, 3-b] Quinoline, Quinolino [3′, 2′: 4, 5] Thieno [3, 2-d] Pyrimidine and Pyrido [2′, 3′: 4, 5] Thieno [2, 3-b] Quinoline Derivatives,” Phosphorus, Sulfur, and Silicon and the Related Elements 181, no. 2 (2006): 279–97. doi:10.1080/104265090970322.
   Web of Science ®Google Scholar
• Lucía Cordeu, Elena Cubedo, Eva Bandrés, Amaia Rebollo, Xabi Sáenz, Hector Chozas, Ma Victoria Domínguez, Mikel Echeverría, Beatriz Mendivil, Carmen Sanmartin, et al, “Biological Profile of New Apoptotic Agents Based on 2,4-Pyrido[2,3-d]Pyrimidine Derivatives,” Bioorganic & Medicinal Chemistry 15, no. 4 (2007): 1659–69. doi:10.1016/j.bmc.2006.12.010.
   PubMed Web of Science ®Google Scholar
• D. Kosk-Kosicka, I. Fomitcheva, and M. M. Lopez, “Mechanism of Inhibition of the Plasma Membrane Ca(2+)-ATPase by Barbiturates,” Biochemistry 35, no. 3 (1996): 900–5. doi:10.1021/bi9518757.
   PubMed Web of Science ®Google Scholar
• M. R. Bhosle, P. Andil, D. Wahul, G. M. Bondle, A. Sarkate, and S. V. Tiwari, “Straightforward Multicomponent Synthesis of Pyrano [2, 3-d] Pyrimidine-2, 4, 7-Triones in β-Cyclodextrin Cavity and Evaluation of Their Anticancer Activity,” Journal of the Iranian Chemical Society 16, no. 7 (2019): 1553–61. doi:10.1007/s13738-019-01633-2.
   Web of Science ®Google Scholar
• S.-H. Kim, A. T. Pudzianowski, K. J. Leavitt, J. Barbosa, P. A. McDonnell, W. J. Metzler, B. M. Rankin, R. Liu, W. Vaccaro, and W. Pitts, “Structure-Based Design of Potent and Selective Inhibitors of Collagenase-3 (MMP-13),” Bioorganic & Medicinal Chemistry Letters 15, no. 4 (2005): 1101–6. doi:10.1016/j.bmcl.2004.12.016.
   PubMed Web of Science ®Google Scholar
• D. M. Neumann, A. Cammarata, G. Backes, G. E. Palmer, and B. S. Jursic, “Synthesis and Antifungal Activity of Substituted 2,4,6-Pyrimidinetrione Carbaldehyde Hydrazones,” Bioorganic & Medicinal Chemistry 22, no. 2 (2014): 813–26. doi:10.1016/j.bmc.2013.12.010.
   PubMed Web of Science ®Google Scholar
• J. T. Bojarski, J. L. Mokrosz, H. J. Bartoń, and M. H. Paluchowska, “Recent Progress in Barbituric Acid Chemistry,” Advances in Heterocyclic Chemistry 38 (1985): 229–97.
   Web of Science ®Google Scholar
• N. R. Penthala, A. Ketkar, K. R. Sekhar, M. L. Freeman, R. L. Eoff, R. Balusu, and P. A. Crooks, “1-Benzyl-2-Methyl-3-Indolylmethylene Barbituric Acid Derivatives: Anti-Cancer Agents That Target Nucleophosmin 1 (NPM1),” Bioorganic & Medicinal Chemistry 23, no. 22 (2015): 7226–33. doi:10.1016/j.bmc.2015.10.019.
   PubMed Web of Science ®Google Scholar
• A. Holý, I. Votruba, M. Masojídková, G. Andrei, R. Snoeck, L. Naesens, E. De Clercq, and J. Balzarini, “6-[2-(Phosphonomethoxy)Alkoxy]Pyrimidines with Antiviral Activity,” Journal of Medicinal Chemistry 45, no. 9 (2002): 1918–29. doi:10.1021/jm011095y.
   PubMed Web of Science ®Google Scholar
• N. O. Mahmoodi, S. Ramzanpour, and F. Ghanbari Pirbasti, “One-Pot Multi-Component Synthesis of 1,4-Dihydropyridines Using Zn(2+) @KSF and Evaluating Their Antibacterial and Antioxidant Activities,” Archiv Der Pharmazie 348, no. 4 (2015): 275–82. doi:10.1002/ardp.201400414.
   PubMed Web of Science ®Google Scholar
• B. D. Dhorajiya, B. S. Bhakhar, and B. Z. Dholakiya, “Synthesis, Characterization, Solvatochromic Properties, and Antimicrobial Evaluation of 5-Acetyl-2-Thioxo-Dihydro-Pyrimidine-4, 6-Dione-Based Chalcones,” Medicinal Chemistry Research 22, no. 9 (2013): 4075–86. doi:10.1007/s00044-012-0395-1.
   Web of Science ®Google Scholar
• L. H. Li, T. L. Wallace, K. A. Richard, and D. E. Tracey, “Mechanism of Antitumor Action of Pyrimidinones in the Treatment of B16 Melanoma and P388 Leukemia,” Cancer Research 45, no. 2 (1985): 532–8.
   PubMed Web of Science ®Google Scholar
• L. Li, T. Wallace, R. Hamilton, and T. DeKoning, “Pharmacological Evaluation of Combination Therapy of P388 Leukemia with Cyclophosphamide and Pyrimidinones,” International Journal of Immunopharmacology 9, no. 1 (1987): 31–9. doi:10.1016/0192-0561(87)90108-1.
   PubMed Web of Science ®Google Scholar
• A. D. Broom, J. L. Shim, and G. L. Anderson, “Pyrido(2,3-d)Pyrimidines. IV. Synthetic Studies Leading to Various Oxopyrido(2,3-d)Pyrimidines,” The Journal of Organic Chemistry 41, no. 7 (1976): 1095–9. doi:10.1021/jo00869a003.
   PubMed Web of Science ®Google Scholar
• E. M. Grivsky, S. Lee, C. W. Sigel, D. S. Duch, and C. A. Nichol, “Synthesis and Antitumor Activity of 2,4-Diamino-6-(2,5-Dimethoxybenzyl)-5-Methylpyrido[2,3-d]Pyrimidine,” Journal of Medicinal Chemistry 23, no. 3 (1980): 327–9. doi:10.1021/jm00177a025.
   PubMed Web of Science ®Google Scholar
• A. R. Bhat, R. S. Dongre, F. A. Almalki, M. Berredjem, M. Aissaoui, R. Touzani, T. B. Hadda, and M. S. Akhter, “Synthesis, Biological Activity and POM/DFT/Docking Analyses of Annulated Pyrano[2,3-d]Pyrimidine Derivatives: Identification of Antibacterial and Antitumor Pharmacophore Sites,” Bioorganic Chemistry 106 (2021): 104480. doi:10.1016/j.bioorg.2020.104480.
   PubMed Web of Science ®Google Scholar
• D. Heber, C. Heers, and U. Ravens, “Positive Inotropic Activity of 5-Amino-6-Cyano-1, 3-Dimethyl-1,2,3,4-Tetrahydropyrido [2, 3-d] Pyrim Idine-2, 4-Dione in Cardiac Muscle from guinea-Pig and Man. Part 6: Compounds with Positive Inotropic Activity,” Die Pharmazie 48, no. 7 (1993): 537–41.
   PubMed Web of Science ®Google Scholar
• M. L. Deb and P. J. Bhuyan, “Synthesis of Some Novel Annulated Pyrido[2,3-d]Pyrimidines via Stereoselective Intramolecular hetero Diels-Alder Reactions of 1-Oxa-1,3-Butadienes,” Beilstein Journal of Organic Chemistry 6, no. 1 (2010): 11. doi:10.3762/bjoc.6.11.
   PubMedGoogle Scholar
• L. R. Bennett, C. J. Blankley, R. W. Fleming, R. D. Smith, and D. K. Tessman, “Antihypertensive Activity of 6-Arylpyrido[2,3-d]Pyrimidin-7-Amine Derivatives,” Journal of Medicinal Chemistry 24, no. 4 (1981): 382–9. doi:10.1021/jm00136a006.
   PubMed Web of Science ®Google Scholar
• C. J. Blankley, L. R. Bennett, R. W. Fleming, R. D. Smith, D. K. Tessman, and H. R. Kaplan, “Antihypertensive Activity of 6-Arylpyrido[2,3-d]Pyrimidin-7-Amine Derivatives. 2. 7-Acyl Amide Analogues,” Journal of Medicinal Chemistry 26, no. 3 (1983): 403–11. doi:10.1021/jm00357a015.
   PubMed Web of Science ®Google Scholar
• C. Mohan, V. Kumar, and M. P. Mahajan, “A Facile Synthesis and Thio-Claisen Rearrangement of 3-Aryl-2-Phenyl-5-Prop-2-Ynylsulfanyl-3H-Pyrimidin-4-Ones: Regioselective Transformation to Thieno [3, 2-d] Pyrimidin-4-Ones,” Tetrahedron Letters 45, no. 31 (2004): 6075–7. doi:10.1016/j.tetlet.2004.05.121.
   Web of Science ®Google Scholar
• A. K. Sharma, S. Jayakumar, M. S. Hundal, and M. P. Mahajan, “Tandem Sigmatropic Shifts in [4 + 2] Cycloaddition Reactions of 1, 3-Diazabuta-1, 3-Dienes with Butadienylketene: Synthesis of Pyrimidinone Derivatives,” Journal of the Chemical Society, Perkin Transactions 1, no. 6 (2002): 774–84. doi:10.1039/b109922c.
   Google Scholar
• S. Sasaki, N. Cho, Y. Nara, M. Harada, S. Endo, N. Suzuki, S. Furuya, and M. Fujino, “Discovery of a Thieno[2,3-d]Pyrimidine-2,4-Dione Bearing a p-Methoxyureidophenyl Moiety at the 6-Position: A Highly Potent and Orally Bioavailable Non-peptide Antagonist for the Human Luteinizing Hormone-Releasing Hormone Receptor,” Journal of Medicinal Chemistry 46, no. 1 (2003): 113–24. doi:10.1021/jm020180i.
   PubMed Web of Science ®Google Scholar
• S. Maddila, R. Pagadala, and S. B. Jonnalagadda, “1,2,4-Triazoles: A Review of Synthetic Approaches and the Biological Activity,” Letters in Organic Chemistry 10, no. 10 (2013): 693–714. doi:10.2174/157017861010131126115448.
   Web of Science ®Google Scholar
• S. V. Bhaskaruni, S. Maddila, W. E. van Zyl, and S. B. Jonnalagadda, “V2O5/ZrO2 as an Efficient Reusable Catalyst for the Facile, Green, One-Pot Synthesis of Novel Functionalized 1, 4-Dihydropyridine Derivatives,” Catalysis Today 309 (2018): 276–81. doi:10.1016/j.cattod.2017.05.038.
   Web of Science ®Google Scholar
• S. V. Bhaskaruni, S. Maddila, W. E. Zyl, and S. B. Jonnalagadda, “RuO2/ZrO2 as an Efficient Reusable Catalyst for the Facile, Green, One-Pot Synthesis of Novel Functionalized Halopyridine Derivatives,” Catalysis Communications 100 (2017): 24–8. doi:10.1016/j.catcom.2017.06.023.
   Web of Science ®Google Scholar
• J. Delaney, E. Clarke, D. Hughes, and M. Rice, “Modern Agrochemical Research: A Missed Opportunity for Drug Discovery?,” Drug Discovery Today 11, no. 17–18 (2006): 839–45. doi:10.1016/j.drudis.2006.07.002.
   PubMed Web of Science ®Google Scholar
• S. A. El-Assiery, G. H. Sayed, and A. Fouda, “Synthesis of Some New Annulated Pyrazolo-Pyrido (or Pyrano) Pyrimidine, Pyrazolopyridine and Pyranopyrazole Derivatives,” Acta Pharmaceutica (Zagreb, Croatia) 54, no. 2 (2004): 143–50.
   PubMedGoogle Scholar
• H. Wamhoff and J. Muhr, “Reaktionen Von Uracilen; Ethoxypyrimido [4, 5-d] Pyrimidine Über Ein Uracil-Carbodiimid-Derivat Und Deren Aminolyse-Und Pyrolyse-Folgeprodukte,” Synthesis 1988, no. 11 (1988): 919–21. doi:10.1055/s-1988-27756.
   Google Scholar
• E. Moosazadeh, E. Sheikhhosseini, D. Ghazanfari, and S. Soltaninejad, “One‐Pot Synthesis of Novel Polysubstituted Furopyran Derivatives via Pseudo Seven‐Component Reaction (6 + 1) of Isocyanides with Bisarylidene Meldrum's Acid Containing Ether Groups,” Journal of Heterocyclic Chemistry 57, no. 5 (2020): 2271–8. doi:10.1002/jhet.3949.
   Web of Science ®Google Scholar
• R. Rezae Tehrani, E. Sheikhhosseini, D. Ghazanfari, and M. R. Akhgar, “Synthesis of New Biological Functionalized Tetra Pyrimidodipyrimidines and Tetra Barbituric Moiety Conation Ether Groups,” Polycyclic Aromatic Compounds, no. 2021 (in press). doi:10.1080/10406638.2021.2009528.
   Google Scholar
• E. Sheikhhosseini, E. Farrokhi, and M. A. Bigdeli, “Synthesis of Novel Tetrahydroquinoline Derivatives from α, α′-Bis (Substituted-Benzylidene) Cycloalkanones,” Journal of Saudi Chemical Society 20 (2016): S227–S230. doi:10.1016/j.jscs.2012.09.018.
   Web of Science ®Google Scholar
• E. Sheikhhosseini, “Design and Effective Synthesis of Novel Furo [2, 3-d] Pyrimidine Derivatives Containing Ethylene Ether Spacers,” Journal of Saudi Chemical Society 22, no. 3 (2018): 337–42. doi:10.1016/j.jscs.2016.05.005.
   Web of Science ®Google Scholar
• A. Rahman, M. I. Choudhary, and W. J. Thomsen, Bioassay Techniques for Drug Development (London: CRC Press, 2001).
   Google Scholar
• C. G. Silva, R. S. Herdeiro, C. J. Mathias, A. D. Panek, C. S. Silveira, V. P. Rodrigues, M. N. Rennó, D. Q. Falcão, D. M. Cerqueira, A. B. M. Minto, et al, “Evaluation of Antioxidant Activity of Brazilian Plants,” Pharmacological Research 52, no. 3 (2005): 229–33. doi:10.1016/j.phrs.2005.03.008.
   PubMed Web of Science ®Google Scholar
• C. Alasalvar, M. Karamać, R. Amarowicz, and F. Shahidi, “Antioxidant and Antiradical Activities in Extracts of Hazelnut Kernel (Corylus Avellana L.) and Hazelnut Green Leafy Cover,” Journal of Agricultural and Food Chemistry 54, no. 13 (2006): 4826–32. doi:10.1021/jf0601259.
   PubMed Web of Science ®Google Scholar
• P. Molyneux, “The Use of the Stable Free Radical Diphenylpicrylhydrazyl (DPPH) for Estimating Antioxidant Activity,” Songklanakarin Journal of Science and Technology 26, no. 2 (2004): 211–9.
   Google Scholar
• F. Liu, V. Ooi, and S. Chang, “Free Radical Scavenging Activities of Mushroom Polysaccharide Extracts,” Life Sciences 60, no. 10 (1997): 763–71. doi:10.1016/s0024-3205(97)00004-0.
   PubMed Web of Science ®Google Scholar
• Y. Mizushima and M. Kobayashi, “Interaction of Anti-Inflammatory Drugs with Serum Proteins, Especially with Some Biologically Active Proteins,” The Journal of Pharmacy and Pharmacology 20, no. 3 (1968): 169–73. doi:10.1111/j.2042-7158.1968.tb09718.x.
   PubMed Web of Science ®Google Scholar
• Hakan Ozer, Münevver Sökmen, Medine Güllüce, Ahmet Adigüzel, Fikrettin Sahin, Atalay Sökmen, Hamdullah Kiliç, and Ozlem Baris, “Chemical Composition and Antimicrobial and Antioxidant Activities of the Essential Oil and Methanol Extract of Hippomarathrum Microcarpum (Bieb.) from Turkey,” Journal of Agricultural and Food Chemistry 55, no. 3 (2007): 937–42. doi:10.1021/jf0624244.
   PubMed Web of Science ®Google Scholar
• A. A. P. Almeida, A. Farah, D. A. Silva, E. A. Nunan, and M. B. A. Glória, “Antibacterial Activity of Coffee Extracts and Selected Coffee Chemical Compounds against Enterobacteria,” Journal of Agricultural and Food Chemistry 54, no. 23 (2006): 8738–43. doi:10.1021/jf0617317.
   PubMed Web of Science ®Google Scholar
• M. Arumugam, A. Mitra, P. Jaisankar, S. Dasgupta, T. Sen, R. Gachhui, U. K. Mukhopadhyay, and J. Mukherjee, “Isolation of an Unusual Metabolite 2-Allyloxyphenol from a Marine Actinobacterium, Its Biological Activities and Applications,” Applied Microbiology and Biotechnology 86, no. 1 (2010): 109–17. doi:10.1007/s00253-009-2311-2.
   PubMed Web of Science ®Google Scholar
• S. Sakat, A. R. Juvekar, and M. N. Gambhire, “In Vitro Antioxidant and Anti-inflammatory Activity of Methanol Extract of Oxalis Corniculata Linn,” International Journal of Pharmacy and Pharmaceutical Sciences 2, no. 1 (2010): 146–55.
   Google Scholar
• L. B. Reller, M. Weinstein, J. H. Jorgensen, and M. J. Ferraro, “Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices,” Clinical Infectious Diseases49, no. 11 (2009): 1749–55. doi:10.1086/647952.
   PubMed Web of Science ®Google Scholar